chrysanthemum indicum extract hamilelikte güvenli mi?
No harmonised CLP reproductive classifications (ECHA Annex VI) or SCCS/CIR safety assessment specifically identifying reproductive hazard for Chrysanthemum indicum extract were found in the referenced regulatory sources. Peer‑reviewed literature describes pharmacology (anti‑inflammatory, antimicrobial) but does not report developmental or teratogenic effects; therefore default score is 0. Sources checked: ECHA Annex VI (no harmonised classification), CosIng (ingredient listing), PubMed (no reproductive/toxicology signals), PubChem (general substance information).
Pregnancy-safe products containing chrysanthemum indicum extract
Related ingredients
Frequently asked questions
- chrysanthemum indicum extract hamilelikte güvenli mi?
- No harmonised CLP reproductive classifications (ECHA Annex VI) or SCCS/CIR safety assessment specifically identifying reproductive hazard for Chrysanthemum indicum extract were found in the referenced regulatory sources. Peer‑reviewed literature describes pharmacology (anti‑inflammatory, antimicrobial) but does not report developmental or teratogenic effects; therefore default score is 0. Sources checked: ECHA Annex VI (no harmonised classification), CosIng (ingredient listing), PubMed (no reproductive/toxicology signals), PubChem (general substance information).
- chrysanthemum indicum extract emzirirken güvenli mi?
- No evidence of lactation/transfer or reproductive toxicity in available regulatory databases or the peer‑reviewed literature. Topical cosmetic use is not associated with systemic reproductive/toxic effects in the sources reviewed, so hazard and mechanism scores remain 0 and exposure is judged negligible for breastfeeding mothers using cosmetic products. (Same data sources as pregnancy.)
- chrysanthemum indicum extract bebek cildi için güvenli mi?
- No data indicating specific developmental or infant toxicity; hazard and mechanism remain 0. Because this is a botanical extract containing small molecules and infant skin has higher permeability, exposure score is increased by +1 (per instruction) to reflect low but measurable potential dermal absorption in 0–3 yr olds. No infant‑specific toxicity studies were identified. Sources: PubMed (no infant toxicity data), CosIng, ECHA Annex VI (no classification), EWG (ingredient listing).
- VeriMom chrysanthemum indicum extract nasıl puanlıyor?
- VeriMom chrysanthemum indicum extract'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte chrysanthemum indicum extract yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.
